Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
12,72%
5-year Growth Rate
R
4/6
5-year Risk Analysis
O
174%
Outlook 12/26
W
-101%
Margin of safety
T
47,63%
Analyst Price Target
H
DOWN
50-week EMA Trend
Company Info
EPS Growth 5Y
44,06%
Revenue growth 5Y
27,28%
Price growth 5Y
5,08%
Market Cap
CHF1,41 B
Long-Term Debt
CHF0,00 B
Quarterly earnings
07/23/2026 (E)
Dividend
CHF1,95
Dividend Yield
2,24%
Industry
Country
Website
ISIN Number
Cosmo Pharmaceuticals N.V. Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
CHF128,29
47.63%
Last Update: 04/03/2026
Analysts: 5
Highest Price Target CHF141,35
Average Price Target CHF128,29
Lowest Price Target CHF103,05
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Cosmo Pharmaceuticals N.V.
SWX:COPN
|
12,16% | 5,08% | 7,09% | 12,72% | 4/6 | 174,36% | -100,79% | 47,63% | DOWN |
